Literature DB >> 12489615

Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.

Beth A Lewis1, Stephen K Koester, Trevor W Bush.   

Abstract

OBJECTIVE: To identify factors influencing pharmacists' decisions about selling syringes to injection drug users (IDUs).
DESIGN: Audiotaped interviews.
SETTING: Denver, Colorado. PARTICIPANTS: Thirty-two pharmacists at 24 pharmacies. INTERVENTION: One-hour semistructured interviews. MAIN OUTCOME MEASURES: Practices regarding syringe sales to IDUs and factors influencing the practices.
RESULTS: Of the 32 pharmacists interviewed, 16 indicated that they sold syringes to all customers ("pro-sell"), 11 refused to sell unless shown proof of diabetic status ("no-sell"), and 5 were "undecided." Several factors influenced the decision to sell. A perceived conflict between prevention of disease and prevention of drug abuse most clearly distinguished the three categories, with pro-sell pharmacists more likely than others to prioritize disease prevention and believe that syringe sales would not increase drug abuse. Business concerns, such as the effect of the presence of IDUs on other customers and the possibility of discarded syringes around the store, were especially prevalent among no-sell and undecided pharmacists. Seventeen pharmacists did not know about Colorado laws governing syringe sales. Four no-sell pharmacists used the laws to justify their decision not to sell, and two undecided pharmacists said they used the law when they did not want to sell syringes to IDU. All pharmacists supported syringe exchange programs.
CONCLUSION: One-half of the pharmacists sold syringes to IDUs, and several more indicated that they would do so if certain concerns were addressed. These data suggest that improved syringe disposal options, continuing education programs, and clarification of existing laws and regulations would encourage more pharmacists in Denver to sell syringes to IDUs.

Entities:  

Mesh:

Year:  2002        PMID: 12489615     DOI: 10.1331/1086-5802.42.0.s46.lewis

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  16 in total

1.  Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.

Authors:  Nickolas Zaller; Alexandra Jeronimo; Jeffrey Bratberg; Patricia Case; Josiah D Rich
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

2.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

3.  Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.

Authors:  Ricky N Bluthenthal; Rachel Anderson; Neil M Flynn; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

4.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

5.  A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.

Authors:  Hansel E Tookes; Alex H Kral; Lynn D Wenger; Gabriel A Cardenas; Alexis N Martinez; Recinda L Sherman; Margaret Pereyra; David W Forrest; Marlene LaLota; Lisa R Metsch
Journal:  Drug Alcohol Depend       Date:  2011-12-29       Impact factor: 4.492

6.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06

7.  Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now?

Authors:  Richard S Garfein; Thomas J Stopka; Patricia B Pavlinac; Alessandra Ross; B Karen Haye; Elise D Riley; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

8.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

9.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2009-02-20

10.  A national physician survey on prescribing syringes as an HIV prevention measure.

Authors:  G E Macalino; D Dhawan Sachdev; J D Rich; C Becker; L J Tan; L Beletsky; S Burris
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.